Ionica Sciences

Deal To Watch
BETA

A better way to test for Lyme disease

Analytics

Raised to Date: $0

Aggregate Commitments $
Platform

SeedInvest

Start Date

09/10/2020

Close Date

11/08/2020

Min. Goal

$25,000

Max. Goal

$750,000

Min. Investment

$1,000

Security Type

Convertible Note

Funding Type

RegCF / RegD 506(C)

Series

Seed

Valuation Cap

$5,500,000

Discount Rate

20%

Weekly Commitments $
Status
Not Funded
Reporting Date

11/08/2020

Days Remaining
Not Funded
% of Min. Goal

0%

% of Max. Goal

0%

Likelihood of Max
Not Funded
Avg. Daily Raise

$0

Momentum
Not Funded
Location

Ithaca, New York

Industry

Healthcare & Pharmaceuticals

Tech Sector

Medtech

Distribution Model

B2B2C

Margin

Medium

Capital Intensity

High

Business Type

Growth

Ionica Sciences, with a $5.5 million valuation cap, is raising crowdfunding on SeedInvest. The company’s technology enables direct detection of Lyme disease with the help of a blood test. Lyme disease is difficult to diagnose, but it becomes easily detectable with the IonLyme Test of Ionica Sciences. The test detects a special protein released into the blood by the bacteria causing the disease. Omar Green, Joel Tabb, and Dean Koch founded Ionica Sciences in 2013. The proceeds of the current crowdfunding round, with a minimum raise of $25,000 and a maximum raise of $750,000, will be used for salaries, research and development, operations, and commercial lab transfer. Ionica Sciences has filed an international patent application under the PCT and received three SBIR contracts from the Department of Defense and the Defense Health Agency.

Summary Profit and Loss Statement
Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-325,300

$-40,643

Summary Balance Sheet
Most Recent Year Prior Year

Cash

$139,160

$300,890

Accounts Receivable

$0

$0

Total Assets

$232,502

$375,663

Short-Term Debt

$293,928

$43,544

Long-Term Debt

$0

$0

Total Liabilities

$293,928

$268,544

Ratings

last updated 11/08/2020

Ratings Platform - Beta Trial

Our new ratings and analytics platform is currently in Beta. To gain access to the Beta platform features, upgrade to a Pro paid account and accept the Beta terms on any page.

For a limited time, use coupon code "TRYMERLIN20" for a free 20 day trial of Kingscrowd Pro and Merlin Beta. Your paid subscription will activate at the end of 20 days. Cancel anytime.
Other Deals

Millennial Fertility Co. on NetCapital

The Millennial Fertility Co. team has been selected as a “Deal to Watch” by KingsCrowd. This distinction is…

Crowd
Biopact on Equifund CFP

Biopact has been selected as a “Deal to Watch” by KingsCrowd. This distinction is reserved for deals selected…

Crowd
Neurotez Inc. on NetCapital

Neurotez has been selected as a “Deal To Watch” by KingsCrowd. This distinction is reserved for deals selected…

Crowd
Create your first portfolio
WELCOME TO YOUR OWN INVESTMENTS PORTFOLIO ON KINGSCROWD.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add Ionica Sciences on SeedInvest
Follow company
Follow Ionica Sciences on SeedInvest